Propecia for hair loss

Propecia Market API Insight

Propecia Market API Insight: Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2017–2022

The Propecia Market Report discuss about recent product innovations and gives an overview on potential regional market shares.

In addition to these, it also includes anticipated facts that are assessed with the aid of an appropriate set of postulations and techniques. The report will provide significant and reliable information on the market clearly in structured format.

Propecia – API Insights, 2017 report provides product and API manufacturers details across the globe along with the location.

The report gives the clear idea on the country wise DMF filed by worldwide companies related to the Propecia.

The Propecia Market report also highlights the patent details of Propecia. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

Scope of the Report:

  • Evaluate the marketing status of Propecia Market to exploit opportunities for generic Propecia development opportunities
  • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details with respect to Propecia
  • API intelligence over Propecia and gaining primary intelligence over Active Ingredient manufacturers by country
  • Make more informed business decisions from insightful and in-depth analysis of the Propecia’s performance

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Propecia Market API Insight

A complete analysis of the competitive landscape of the Propecia is provided in the report. The report provides Forecasted Global Sales from 2017-2022 (in million USD). Propecia Market report gives Reginal supply as well as sales data. The report showcases the business strategists, Growth Prospects and historical & futuristic cost and revenue over the coming years.

Major Tables of contents:

  • Propecia Overview
  • Product Description
  • Product Details by country
  • Propecia Market Historical Global Sales
  • Propecia Market Forecasted Global Sales

Finally, the Propecia report offers a whole consequential analysis of the parent Propecia Market, key tactics, Manufacturers details and upcoming segments. It covers the market landscape and its growth prospects over the coming years.

So, Propecia Market report is a complete guide for new aspirant to understand the market trends and plan the business accordingly.


Hair growth drugs may cause erectile dysfunction

There is a higher risk of persistent erectile dysfunction (ED) among men who use drugs to treat hair loss, a research has said.

Erectile dysfunction is the inability to get or maintain an erection firm enough to have sexual intercourse.

The research revealed that exposure to hair growth drugs, which have finasteride or dutasteride as active ingredients, have greater chances of causing ED than other risk factors like diabetes, smoking, and hypertension.

The study found that persistent erectile dysfunction continued long after discontinued usage of the drugs and the use of sex enhancement drugs.

The study was carried out by researchers from Northwestern University in the United States.

“Prior to the new study, there was no strong evidence that finasteride and dutasteride cause sexual problems that continue after men stop taking them.

“Our study shows men who take finasteride or dutasteride can get persistent erectile dysfunction, in which they will not be able to have normal erections for months or years after stopping finasteride or dutasteride,” said Steven Belknap, a research assistant professor at Northwestern University Feinberg school of medicine.

“Finasteride and dutasteride are drugs that are male hormone blockers.

These drugs block the conversion of testosterone, primary male sex hormone, to its more active form, 5 alpha dihydrotestosterone.

“Finasteride is prescribed to some men with prostate enlargement or baldness. Dutasteride is prescribed to some men with prostate enlargement.

“The association between debilitating sexual dysfunction and exposure to finasteride or dutasteride should be of particular interest to prescribers and patients considering medical management of androgenic alopecia (hair loss) or symptomatic treatment of enlarged prostate.”

The study, which was published in PeerJ, said 167 of the 11,909 men studied in the research developed persistent erectile dysfunction that continued for about 1,348 days after stopping usage of the drugs.

Men under age 42 who had more than 205 days of finasteride or dutasteride exposure had 4.9% higher risk of persistent erectile dysfunction than men with reduced exposure, the researchers found.


propecia side effects